These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2419289)

  • 21. Molecular analysis of HLA-DP specificities HLA-DPw1, -DPw2 and -DPw4: DP beta chain heterogeneity correlates with PLT subtyping.
    Baas EJ; Bontrop RE; Otting N; Giphart MJ
    Tissue Antigens; 1988 Jan; 31(1):5-13. PubMed ID: 2829386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.
    Rosen-Bronson S; Johnson AH; Hartzman RJ; Eckels DD
    Immunogenetics; 1986; 24(5):286-97. PubMed ID: 3491043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.
    Shaw S; Johnson AH; Shearer GM
    J Exp Med; 1980 Sep; 152(3):565-80. PubMed ID: 6967946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset.
    Jaraquemada D; Navarrete C; Ollier W; Awad J; Okoye R; Festenstein H
    Hum Immunol; 1986 Jul; 16(3):259-70. PubMed ID: 2424875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human influenza virus-specific T helper cell clones can be restricted by MHC products different from serologically defined HLA-DR antigens.
    Fleischer B
    Tissue Antigens; 1983 Mar; 21(3):238-45. PubMed ID: 6190261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell clones with similar antigen specificity may be restricted by DR, MT(DC), or SB class II HLA molecules.
    Qvigstad E; Moen T; Thorsby E
    Immunogenetics; 1984; 19(5):455-60. PubMed ID: 6427104
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for polymorphism of MB3 antigens among three HLA-D clusters associated with HLA-DR4.
    Ikeda H; Kasahara M; Ogasawara K; Takenouchi T; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M
    Immunogenetics; 1984; 19(5):381-90. PubMed ID: 6202628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-Dw/LD directed cytotoxic T cell clones.
    Anichini A; Bach FH
    Hum Immunol; 1984 Jul; 10(3):153-64. PubMed ID: 6204957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of two cis-encoded HLA-DQ molecules that carry distinct alloantigenic specificities.
    Johnson JP; Wank R
    J Exp Med; 1984 Nov; 160(5):1350-9. PubMed ID: 6208309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of human T-lymphocyte clones (TLCs) specific for HLA-region gene products.
    Eckels DD; Hartzman RJ
    Immunogenetics; 1982; 16(2):117-33. PubMed ID: 6183195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen.
    Triebel F; de Roquefeuil S; Blanc C; Charron DJ; Debre P
    Hum Immunol; 1986 Mar; 15(3):302-15. PubMed ID: 2420767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones.
    Eckels DD; Lake P; Lamb JR; Johnson AH; Shaw S; Woody JN; Hartzman RJ
    Nature; 1983 Feb; 301(5902):716-8. PubMed ID: 6186920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for expression of class II MHC public determinants detected by T-cell clones.
    Nikaein A; McQueen K; Gobeli M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):626-7. PubMed ID: 2468225
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
    Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen recognition by MHC-incompatible cells of a human mismatched chimera.
    Roncarolo MG; Yssel H; Touraine JL; Bacchetta R; Gebuhrer L; De Vries JE; Spits H
    J Exp Med; 1988 Dec; 168(6):2139-52. PubMed ID: 2462006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.